Roivant Sciences
ROIV
ROIV
337 hedge funds and large institutions have $7.59B invested in Roivant Sciences in 2025 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 125 increasing their positions, 95 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 56
0% more funds holding
Funds holding: 337 → 337 (0)
2.23% less ownership
Funds ownership: 75.68% → 73.45% (-2.2%)
Holders
337
Holding in Top 10
15
Calls
$114M
Puts
$44.4M
Top Buyers
| 1 | +$65.1M | |
| 2 | +$63.8M | |
| 3 | +$50M | |
| 4 |
SC
Stempoint Capital
New York
|
+$44.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$37.4M |
Top Sellers
| 1 | -$243M | |
| 2 | -$132M | |
| 3 | -$54.5M | |
| 4 |
PP
Pertento Partners
London,
United Kingdom
|
-$35M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29.1M |
